已获批特殊医学用途婴儿配方食品营养成分含量与《新国标》（GB 25596-2025）比较研究

doi:10.12372/jcp.2025.25e0568

Abstract

Abstract:

The National Health Commission and the State Administration for Market Regulation jointly promulgated the "National Food Safety Standard: General Standard for Infant Formula for Special Medical Purposes" (GB 25596-2025, hereinafter referred to as the "New Standard") on March 16, 2025. The New Standard introduces comprehensive optimizations regarding the reference ranges, content requirements, and testing methods for macronutrients (proteins, carbohydrates, and fats), vitamins, minerals, and other optional components. Additionally, it expands the product categories from the original 6 to 13 types, with corresponding technical specifications established for each category. Currently, all approved infant formula products for special medical purposes (hereinafter referred to as "FSMP for infants") in the market are manufactured in compliance with the 2010 version of the standard (GB 25596-2010, "Old Standard"). This article will focus on analyzing the changes in mandatory and optional component requirements, while evaluating the compliance status of approved products with the New Standard. The findings aim to assist clinical pediatricians in accurately understanding the key revisions of the New Standard, thereby enabling more scientifically appropriate nutritional support plans for infants with special medical conditions.

Key words: infant formula foods for special medical purposes, new standards, approved, comparative study

CLC Number:

GUO Zhuoyu. A comparative study on the nutritional content of approved special medical purpose infant formula food with the "New National Standard (GB 25596-2025)"[J].Journal of Clinical Pediatrics, 2025, 43(11): 837-844.

Figures/Tables 4

Table 1

Comparison of essential components in infant formula for special medical purposes between old and new national standards"

类别	营养成分	指标要求				检验方法
		每100 kJ		每100 kcal		检验方法
		《旧国标》	《新国标》	《旧国标》	《新国标》	《旧国标》	《新国标》
蛋白质、脂肪和碳水化合物指标	蛋白质/g	0.45~0.70	0.43↓~0.84↑	1.88~2.93	1.8↓~3.5↑	GB 5009.5	GB 5009.5
	脂肪/g	1.05~1.40	0.84↓~1.43↑	4.39~5.86	3.5↓~6.0↑	GB 5413.3	GB 5009.6
	亚油酸/g	0.07~0.33	0.07~0.33	0.29~1.38	0.3~1.4	GB 5413.27	GB 5009.168
	α-亚麻酸/mg	12~NS	12~NS	50~NS	50~NS	GB 5413.27	GB 5009.168
	亚油酸与α-亚麻酸比值	5∶1~15∶1	5∶1~15∶1	5∶1~15∶1	5∶1~15∶1	－	－
	碳水化合物/g	2.2~3.3	2.2~3.3	9.2~13.8	9.0~14.0	－	－
维生素指标	维生素A/μg RE	14~43	14~43	59~180	60~180	GB 5413.9	GB 5009.82
	维生素D/μg	0.25~0.60	0.48↑~1.20↑	1.05~2.51	2.0↑~5.0↑	GB 5413.9	GB 5009.296
	维生素E/mg α-TE	0.12~1.20	0.12~1.20	0.50~5.02	0.5~5.0	GB 5413.9	GB 5009.82
	维生素K₁/μg	1.0~6.5	0.96²⁾~6.45²⁾	4.2~27.2	4.0²⁾~27.0²⁾	GB 5413.10	GB 5009.158
	维生素B₁/μg	14~72	14~72	59~301	60~300	GB 5413.11	GB 5009.84
	维生素B₂/μg	19~119	19~120²⁾	80~498	80~500²⁾	GB 5413.12	GB 5009.85
	维生素B₆/μg	8.5~45.0	8.4²⁾~41.8↓	35.6~188.3	35²⁾~175↓	GB 5413.13	GB 5009.154
	维生素B₁₂/μg	0.025~0.360	0.024²⁾~0.359²⁾	0.105~1.506	0.10²⁾~1.50²⁾	GB 5413.14	GB 5009.285
	烟酸(烟酰胺)/μg	70~360	96↑~359²⁾	293~1 506	400↑~1 500²⁾	GB 5413.15	GB 5009.89
	叶酸/μg	2.5~12.0	2.4²⁾~12.0	10.5~50.2	10²⁾~50²⁾	GB 5413.16	GB 5009.211
	泛酸/μg	96~478	96~478	402~2 000	400~2 000	GB 5413.17	GB 5009.210
	维生素C/mg	2.5~17.0	2.4²⁾~16.7²⁾	10.5~71.1	10²⁾~70²⁾	GB 5413.18	GB 5413.18
	生物素/μg	0.4~2.4	0.36²⁾~2.39²⁾	1.5~10.0	1.5~10.0	GB 5413.19	GB 5009.259
	胆碱/mg¹⁾	1.7~12.0	4.8↑~23.9↑	7.1~50.2	20↑~100↑	GB/F 5413.20	GB 5413.20
矿物质指标	钠/mg	5~14	NS~20↑	21~59	NS~84	GB 5413.21	GB 5009.91
	钾/mg	14~43	17↑~54↑	59~180	70~225	GB 5413.21	GB 5009.91
	铜/μg	8.5~29.0	8.4²⁾~28.7²⁾	35.6~121.3	35~120	GB 5413.21	GB 5009.13
	镁/mg	1.2~3.6	1.2~3.6	5.0~15.1²⁾	5.0~15.0	GB 5413.21	GB 5009.241
	铁/mg	0.10~0.36	0.10~0.48↑	0.42~1.51	0.42~2.00↑	GB 5413.21	GB 5009.90
	锌/mg	0.12~0.36	0.12~0.36	0.50~1.51	0.50~1.50	GB 5413.21	GB 5009.14
	锰/μg	1.2~24.0	0.24↓~23.90²⁾	5.0~100.4	1.0↓~100.0²⁾	GB 5413.21	GB 5009.242
	钙/mg	12~35	12~43↑	50~146	50~180↑	GB 5413.21	GB 5009.92
	磷/mg	6~24	6~26↑	25~100	25~110↑	GB 5413.22	GB 5009.87
	钙磷比值	1∶1~2∶1	1∶1~2∶1	1∶1~2∶1	1∶1~2∶1	－	－
	碘/μg	2.5~14.0	3.6↑~14.1²⁾	10.5~58.6	15↑~59²⁾	GB 5413.23	GB 5009.267
	氯/mg	12~38	NS~52↑	50~159	NS~218↑	GB 5413.24	GB 5009.44
	硒/μg	0.48~1.90	0.48~2.06↑	2.01~7.95	2.0~8.6↑	GB 5009.93	GB 5009.93

Table 1

Table 2

Table 3

Comparison of essential component differences in approved infant formulas for special medical purposes under the new national standard"

指标	类别	特医婴配方食品		无乳糖或低乳糖配方		乳蛋白部分水解配方		乳蛋白深度水解或氨基酸配方		早产/低出生体重配方		母乳营养补充剂		氨基酸代谢障碍配方
指标	类别	个数	达标率 %	个数	达标率 %	个数	达标率 %	个数	达标率 %	个数	达标率 %	个数	达标率 %	个数	达标率 %
蛋白质、脂肪和碳水化合物	蛋白质	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	脂肪	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	亚油酸	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	α-亚麻酸	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	亚油酸与α-亚麻酸比值	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	碳水化合物	57	100	14	100	11	100	5	100	19	100	5	100	3	100
维生素	维生素A	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素D	21	36.84	0	0	0	0	0	0	16	84.21	5	100	0	0
	维生素E	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素K₁	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素B₁	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素B₂	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素B₆	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素B₁₂	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	烟酸(烟酰胺)	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	叶酸	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	泛酸	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	维生素C	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	生物素	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	胆碱¹⁾	17	29.82	3	21.43	5	45.45	0	0	6	31.58	1	20	2	66.67
矿物质指标	钠	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	钾	55	96.49	14	100	11	100	5	100	17	89.47	5	100	3	100
	铜	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	镁	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	铁	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	锌	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	锰	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	钙	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	磷	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	钙磷比值	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	碘	38	66.67	5	35.71	6	54.55	2	40	17	89.47	5	100	3	100
	氯	57	100	14	100	11	100	5	100	19	100	5	100	3	100
	硒	57	100	14	100	11	100	5	100	19	100	5	100	3	100

Table 3

Table 4

References 20

[1]	国家卫生健康委员会, 国家市场监督管理总局.食品安全国家标准特殊医学用途婴儿配方食品: GB 25596-2025[S]. 北京: 中国标准出版社, 2025.
	National Health Commission of the People's Republic of China, State Administration for Market Regulation.National food safety standard: infant formula for special medical purposes: GB 25596-2025[S]. Beijing: Standards Press of China, 2025.
[2]	国家卫生健康委员会食品安全标准与监测评估司. 婴幼儿配方食品系列标准问答[EB/OL]. [2021-03]. https://www.nhc.gov.cn/sps/c100087/202103/e39973ee9f27428b91783c4149a337fc.shtml.
	Department of Food Safety Standards and Monitoring, National Health Commission. Q&A on series standards for infant and young children formula[EB/OL]. [2021-03]. https://www.nhc.gov.cn/sps/c100087/202103/e39973ee9f27428b91783c4149a337fc.shtml.
[3]	国家卫生健康委员会, 国家市场监督管理总局. 《食品安全国家标准特殊医学用途婴儿配方食品通则》(GB 25596-2025)解读材料[EB/OL]. [2025-03-16]. https://sppt.cfsa.net.cn:8086/db?type=3&guid=B647601A-14F5-43BD-9712-E8C254E1F2CA.
	National Health Commission, State Administration for Market Regulation. Interpretation of GB 25596-2025 "General standard for infant formula for special medical purposes"[EB/OL]. [2025-03-16]. https://sppt.cfsa.net.cn:8086/db?type=3&guid=B647601A-14F5-43BD-9712-E8C254E1F2CA.
[4]	李保龙, 高慧宇, 张雪松, 等. 2017-2022年中国市售较大婴儿配方乳粉必需成分含量与新国标比较研究[J]. 卫生研究, 2023, 52(3): 394-398.
	Li BL, Gao HY, Zhang XS, et al. Comparative study on the essential composition content of commercial follow-up formula for older infant with the requirements in the new national food safety standard in China from 2017 to 2022[J]. Weisheng Yanjiu, 2023, 52(3): 394-398.
[5]	Motlagh AJ, Davoodvandi A, Saeieh SE. Association between vitamin D level in mother's serum and the level of vitamin D in the serum of pre-term infants[J]. BMC Pediatr, 2023, 23(1): 97. doi: 10.1186/s12887-023-03854-0 pmid: 36859242
[6]	Romero-Lopez M, Tyson JE, Naik M, et al. Randomized controlled trial of enteral vitamin D supplementation (ViDES) in infants <28 weeks gestational age or <1000 g birth weight: study protocol[J]. Trials, 2024, 25(1): 423. doi: 10.1186/s13063-024-08274-8 pmid: 38943179
[7]	Romero-Lopez M, Naik M, Holzapfel LF, et al. Survey of vitamin D supplementation practices in extremely preterm infants[J]. Pediatr Res, 2025, 97(3): 1009-1015.
[8]	Qiao W, Chen J, Zhang M, et al. A cohort study of vitamins contents in human milk from maternal-infant factors[J]. Front Nutr, 2022, 9: 993066.
[9]	中国营养学会. 中国居民膳食营养素参考摄入量(2023版)[M]. 北京: 人民卫生出版社, 2023.
	Chinese Nutrition Society. Chinese dietary reference intakes (2023)[M]. Beijing: People's Medical Publishing House, 2023.
[10]	Fang C, Zhou W. Genetic background of neonatal hypokalemia[J]. Pediatr Nephrol, 2025, 40(2): 301-317.
[11]	Mäkelä PM, Immeli L, Leskinen M, et al. Actual electrolyte intake during the first week of life and morbidity in very-low-birthweight infants[J]. Acta Paediatr, 2024, 113(8): 1833-1844.
[12]	Kenny TC, Scharenberg S, Abu-Remaileh M, et al. Cellular and organismal function of choline metabolism[J]. Nat Metab, 2025, 7(1): 35-52.
[13]	Michaela M, Christoph M, Christine H, et al. Choline and betaine levels in plasma mirror choline intake in very preterm infants[J]. Nutrients, 2023, 15(22): 4758.
[14]	Obeid R, Schön C, Derbyshire E, et al. A Narrative review on maternal choline intake and liver function of the fetus and the infant; implications for research, policy, and practice[J]. Nutrients, 2024, 16(2): 260.
[15]	Hirsch TI, Wang SZ, Fligor SC, et al. Fat malabsorption in short bowel syndrome: a review of pathophysiology and management[J]. Nutr Clin Pract, 2024, 39 (Suppl 1): S17-S28.
[16]	Decsi T, Marosvölgyi T, Szabó É. Docosahexaenoic acid in formulas for term infants: the way from pioneer idea to mandatory dietary recommendation[J]. Life (Basel), 2023, 13(6): 1326.
[17]	Toca MDC, Parisi C, Fernández A, et al. Cow's milk allergy treatment. An expert consensus[J]. Arch Argent Pediatr, 2024, 122(5): e202410404.
[18]	Wilsey MJ, Baran JV, Lamos L, et al. Short-term symptom improvement in infants with suspected cow's milk protein allergy using amino acid formula: a prospective cohort analysis[J]. Front Nutr, 2023, 10: 1208334.
[19]	Błażowski Ł, Podlecka D, Brzozowska A, et al. Clinical phenotypes of severe cow's milk protein allergy with various responses to amino acid-based formula[J]. Nutrients, 2025, 17(11): 1809.
[20]	国家市场监督管理总局特殊食品安全监督管理司. 特殊医学用途婴儿配方食品按新国标注册问答[EB/OL]. [2025-04-20] https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/tssps/art/2025/art_43a4e9c97daf465983078ecaa9479062.html.
	Special Food Safety Supervision and Administration Department, State Administration for Market Regulation. Q&A on registration of infant formula for special medical purposes under new national standard[EB/OL]. [2025-04-20]. https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/tssps/art/2025/art_43a4e9c97daf465983078ecaa9479062.html.

可选择成分	指标要求				检验方法
可选择成分	《旧国标》/100 kJ^-1	《新国标》/100 kJ^-1	《旧国标》/100 kcal^-1	《新国标》/100 kcal^-1	《旧国标》	《新国标》
胆碱/mg¹⁾	1.7~12.0	4.8↑~23.9↑	7.1~50.2	20↑~100↑	GB/T 5413.20	GB 5413.20
铬/μg	0.4~2.4	0.4~2.4	1.5~10	1.5~10.0	－	GB 5009.123
钼/μg	0.4~2.4	0.4~2.4	1.5~10	1.5~10.0	－	GB 5009.297
肌醇/mg	1.0~9.5	1.0~9.6²⁾	4.2~39.7	4~40²⁾	GB 5413.25	GB 5009.270
牛磺酸/mg	NS~3	0.8~4.0↑	NS~13	3.5~16.7↑	GB 5413.26	GB 5009.169
左旋肉碱/mg	0.3~NS	0.3~NS	1.3~NS	1.3~NS	－	GB 5009.300
DHA/mg³⁾	NS~0.5	3.6~9.6↑	NS~0.5	15~40↑	GB 5413.27	GB 5009.168
AA/ARA/mg³⁾	NS~1	NS~19.1↑	NS~1	NS~80↑	GB 5413.27	GB 5009.168

A comparative study on the nutritional content of approved special medical purpose infant formula food with the "New National Standard (GB 25596-2025)"

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 20

Related Articles 15

Metrics

Comments

Recommended 0

可选择成分	特医婴配方食品			无乳糖配方或低乳糖配方			乳蛋白部分水解配方			乳蛋白深度水解配方或氨基酸配方
可选择成分	《旧国标》个数	《新国标》个数	达标率 %	《旧国标》个数	《新国标》个数	达标率 %	《旧国标》个数	《新国标》个数	达标率 %	《旧国标》个数	《新国标》个数	达标率 %
胆碱¹⁾	54	17	31.48	14	3	21.43	11	5	45.46	5	0	0
铬	2	2	100	0	0	－	0	0	－	1	1	100
钼	2	2	100	0	0	－	0	0	－	1	1	100
肌醇	53	53	100	13	13	100	11	11	100	5	5	100
牛磺酸	53	53	100	12	12	100	11	11	100	5	5	100
左旋肉碱	51	51	100	13	13	100	11	11	100	5	5	100
DHA	51	17	33.33	14	2	14.28	10	1	10	5	1	20
AA/ARA	49	49	100	14	14	100	10	10	100	5	5	100
可选择成分	早产/低出生体重婴儿配方				母乳营养补充剂				氨基酸代谢障碍配方
可选择成分	《旧国标》个数		《新国标》个数	达标率 %	《旧国标》个数		《新国标》个数	达标率 %	《旧国标》个数		《新国标》个数	达标率 %
胆碱¹⁾	19		6	31.58	2		1	50	3		2	66.67
铬	0		0	－	0		0	－	1		1	100
钼	0		0	－	0		0	－	1		1	100
肌醇	19		19	100	2		2	100	3		3	100
牛磺酸	19		19	100	3		3	100	3		3	100
左旋肉碱	17		17	100	2		2	100	3		3	100
DHA	19		11	57.89	2		1	50	1		1	100
AA/ARA	18		18	100	1		1	100	1		1	100

[1]	CHEN Chao. Significance of introducing the concept of “small vulnerable newborns” [J]. Journal of Clinical Pediatrics, 2025, 43(11): 803-806.
[2]	LI Jing, LIANG Xuxia, ZHANG Jihong, ZHANG Chun, LU Yanqun, WU Hua. Parental factors associated with singleton small vulnerable neonates: a 5-year retrospective cohort study [J]. Journal of Clinical Pediatrics, 2025, 43(11): 807-815.
[3]	HUAN Peng, WANG Xiaoling, GAO Qiang, LUO Lijuan, DONG Wenbin, LEI Xiaoping. Risk factors of post-discharge catch-up growth in very preterm infants [J]. Journal of Clinical Pediatrics, 2025, 43(11): 816-822.
[4]	YANG Mengyuan, CHEN Yanshan, PEI Wanjun, LI Jing, DONG Huifang. A single - center study on extrauterine growth retardation in preterm infants after surgery for necrotizing enterocolitis [J]. Journal of Clinical Pediatrics, 2025, 43(11): 823-829.
[5]	ZHANG Zhihai, TANG Xinye, YAO Hongbing, WANG Bing, XIAO Ling, YANG Yang. Application of drug-induced sleep endoscopy in pediatric obstructive sleep apnea [J]. Journal of Clinical Pediatrics, 2025, 43(11): 830-836.
[6]	JI Yinwen, HUANG Xiaomin, ZOU Chaochun, MAO Shanshan. Analysis of the characteristics of clinical trials for pediatric rare diseases based on the Chinese Clinical Trial Registry [J]. Journal of Clinical Pediatrics, 2025, 43(11): 845-853.
[7]	WAN Ling, CHEN Chaoying, TU Juan, LI Huarong, SUN Jinshan. Clinical characteristics and gene variation analysis of 5 Schimke immunoosseous dysplasia children [J]. Journal of Clinical Pediatrics, 2025, 43(11): 854-859.
[8]	GAO Weiwei, ZOU Yingxue, GUO Yongsheng, GUO Run. Clinical and imaging features of children with bocavirus pneumonia associated with plastic bronchitis [J]. Journal of Clinical Pediatrics, 2025, 43(11): 860-865.
[9]	XU Chunna, TANG Yu, ZHAO Shunying, SU Yanyan, LI Xiao, ZHANG Lei. Clinical characteristics analysis of 39 cases of Chlamydia pneumoniae pneumonia in children [J]. Journal of Clinical Pediatrics, 2025, 43(11): 866-871.
[10]	ZHANG Ting, MA Ming, JIANG Mizu. Progress in the treatment of infantile hypercalcemia type 1 induced by CYP24A1 variants [J]. Journal of Clinical Pediatrics, 2025, 43(11): 872-877.
[11]	FENG Xiwei, GONG Fangqi. Progress on the application of infliximab in IVIG-resistant Kawasaki disease [J]. Journal of Clinical Pediatrics, 2025, 43(11): 878-882.
[12]	CHANG Guoying, YANG Fan, YIN Lei, YUAN Jiajun, WANG Xiumin. From "Passive Continuation" to "Active Transition": Clinical practice and reflection on continuation therapy for pediatric and adolescent rare diseases [J]. Journal of Clinical Pediatrics, 2025, 43(10): 723-726.
[13]	LIU Xinzhu, XING Xiaodong, LIU Yu, LIU Yan, JIANG Wengao, ZHANG Jian, YANG Junlin. Efficacy and safety of nusinersen in spinal muscular atrophy patients with scoliosis [J]. Journal of Clinical Pediatrics, 2025, 43(10): 727-733.
[14]	HU Jiayue, YING Lingwen, CHANG Guoying, LI Juan, YANG Fan, WANG Cuijin, YU Tingting, YAO Ruen, LUO Chengjuan, Wang Xiumin. Clinical phenotypes, genetic analysis and allogeneic hematopoietic stem cell transplantation efficacy of 8 children with metachromatic leukodystrophy [J]. Journal of Clinical Pediatrics, 2025, 43(10): 734-741.
[15]	LIU Xin, ZHANG Zibo, LI He, ZHOU Yuhui, ZHANG Bing, LIU Li. Efficacy of TNF-α antagonist in treating 6 cases of chronic recurrent multifocal osteomyelitis in children [J]. Journal of Clinical Pediatrics, 2025, 43(10): 742-748.